- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Good Governance for Medicines
- All > Medicine Programme Coordination > Programme Coordination
- Keywords > access to medicines
- Keywords > accountability - pharmaceutical sector
- Keywords > availability, affordability, and quality of pharmaceutical products
- Keywords > corruption
- Keywords > key achievements
- Keywords > legal framework
- Keywords > MeTA - The Medicines Transparency Alliance
- Keywords > multi-stakeholder approach
- Keywords > pharmaceutical sector - good governance
- Keywords > transparency
(2016; 12 pages)
The Medicines Transparency Alliance (MeTA) began as a pilot in Uganda in 2009. The programme aimed to contribute to good governance, transparency and accountability across the medicines chain, through the engagement of all stakeholders with an interest in the outcome of the medicines market.
A 12-member MeTA Council was established with co-chairs from the Ministry of Health (MOH), civil society and the private sector. A coordinator was made responsible for day-to-day operations of MeTA, supported by a small secretariat. The council established committees to lead specific areas of work.
To gain a better understanding of the pharmaceutical situation in Uganda, MeTA undertook a comprehensive programme of surveys to build a robust evidence base for policy dialogue. It also built the capacity of civil society organisations to better engage with government.
Uganda was one of seven countries to adopt MeTA. The programme has also been active in Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, and Zambia. The programme is run with funding from the UK Government through the Department for International Development (DFID).